Shrinkage estimation for dose-response modeling in phase II trials with multiple schedules. (arXiv:2005.04261v1 [stat.AP]) http://arxiv.org/abs/2005.04261
CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.